Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

17.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.5K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

8.7K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
8.7K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

3.3K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
3.3K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

16.1K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.1K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

10.5K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
10.5K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

5.3K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nrf2 Overexpression in Spontaneously Hypertensive Rats Enhances Adipose Tissue Metabolism through Redox-Mediated Suppression of Mitochondrial Oxidative Phosphorylation.

Physiological research·2025
Same author

Variability of Clinical Phenotypes Caused by Isolated Defects of Mitochondrial ATP Synthase.

Physiological research·2024
Same author

THE EFFECT OF THERAPY WITH INSULIN ANALOGUES (ASPART AND GLARGINE) ON OXIDATIVE STRESS PARAMETERS IN PATIENTS WITH TYPE 1 DIABETES MELLITUS.

Acta endocrinologica (Bucharest, Romania : 2005)·2024
Same author

Czech Footprints in the Bioenergetics Research.

Physiological research·2024
Same author

Conplastic strains for identification of retrograde effects of mitochondrial dna variation on cardiometabolic traits in the spontaneously hypertensive rat.

Physiological research·2022
Same author

Role of cytochrome c oxidase nuclear-encoded subunits in health and disease.

Physiological research·2020

Related Experiment Video

Updated: Dec 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.0K

Current progress in the therapeutic options for mitochondrial disorders.

E Koňaříková1, A Marković, Z Korandová

  • 1Laboratory of Bioenergetics, Institute of Physiology Czech Acad. Sci., Prague, Czech Republic. eliska.konarikova@fgu.cas.cz, tomas.mracek@fgu.cas.cz.

Physiological Research
|November 1, 2020
PubMed
Summary

Mitochondrial disorders, characterized by impaired cellular energy production, have limited treatments. This review explores emerging therapies including compounds, metabolic interventions, and genomic approaches for these complex genetic diseases.

More Related Videos

Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.6K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.6K

Related Experiment Videos

Last Updated: Dec 3, 2025

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

12.0K
Generation of Human Brain Organoids for Mitochondrial Disease Modeling
08:09

Generation of Human Brain Organoids for Mitochondrial Disease Modeling

Published on: June 21, 2021

6.6K
Author Spotlight: Decoding Mitochondrial Aging
08:48

Author Spotlight: Decoding Mitochondrial Aging

Published on: June 30, 2023

4.6K

Area of Science:

  • Biochemistry and Genetics
  • Cellular Biology
  • Neurology

Background:

  • Mitochondrial disorders exhibit significant genetic and clinical variability.
  • A common feature is impaired mitochondrial respiratory chain activity, crucial for cellular energy production.
  • Current treatment options are limited, often relying on supportive care.

Purpose of the Study:

  • To review current and emerging therapeutic strategies for mitochondrial disorders.
  • To highlight advancements in treatment beyond supportive care.
  • To discuss various therapeutic modalities under investigation.

Main Methods:

  • Review of current and preclinical research on mitochondrial disorder treatments.
  • Focus on small compounds, metabolic interventions, and genomic approaches.
  • Analysis of ongoing clinical trials for novel therapies.

Main Results:

  • Next-Generation Sequencing has improved diagnostics but not treatment accessibility.
  • Potential therapeutic targets have been identified through extensive research.
  • Numerous compounds and interventions are progressing through clinical trials.

Conclusions:

  • Despite diagnostic advances, effective treatments for mitochondrial disorders remain scarce.
  • Emerging therapies show promise, including small molecules, metabolic modulation (e.g., endurance training, ketogenic diet), and gene-based strategies.
  • Further research and clinical trials are essential to develop effective treatments for patients.